A 37-year-old Wisconsin man was in custody Saturday after Bettendorf Police say they found a stolen gun, fentanyl pills, and ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

Longboard has commenced the Phase III DEEp OCEAN Study of bexicaserin for treating seizures linked to DEEs in two years and ...

Generated $50.0 million in net revenue from sales of LUMRYZ™ ----2,300 patients on LUMRYZ as of September 30th, including 700 patients that ...

Recent developments driving growth in this area make the advanced, AI-supported digitization of pharma pipelines inevitable.

Recently, I have been scrutinizing nutrition and supplement labels more than I normally do ... The abuse potential of kratom ...

Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic ...

Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 – ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

Among a blizzard of announcements on Tuesday, the president-elect said he had chosen Elon Musk and Vivek Ramaswamy, two of ...

DWTX READ THE FULL DWTX RESEARCH REPORT Business Update Phase 2 Long COVID Results Expected Soon Dogwood Therapeutics, Inc.

Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m. See why I think selling AXSM stock on any ...